[1]李浩明,曲玉清,王先令,等.286例功能性胰腺神经内分泌肿瘤的临床特点及治疗:一项单中心回顾性研究[J].国际内分泌代谢杂志,2021,41(03):178-183.[doi:10.3760/cma.j.cn121383-20200729-07073]
　Li Haoming,Qu Yuqing,Wang Xianling,et al.Clinical characteristics and management of 286 patients with functional pancreatic neuroendocrine neoplasms: a single institution retrospective study[J].International Journal of Endocrinology and Metabolism,2021,41(03):178-183.[doi:10.3760/cma.j.cn121383-20200729-07073]
点击复制

286例功能性胰腺神经内分泌肿瘤的临床特点及治疗:一项单中心回顾性研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年03期
页码:
178-183
栏目:
论著
出版日期:
2021-05-20

文章信息/Info

Title:
Clinical characteristics and management of 286 patients with functional pancreatic neuroendocrine neoplasms: a single institution retrospective study
作者:
李浩明1; 2; 曲玉清1; 3; 王先令1; 郭清华1; 陈予龙1; 裴育1; 杜锦1; 闫文华1; 臧丽1; 谷伟军1; 窦京涛1; 巴建明1; 吕朝晖1; 母义明1
1中国人民解放军总医院第一医学中心内分泌科,北京 100089; 2河北省涉县医院内分泌科,邯郸 056400; 3烟台毓璜顶医院内分泌科 264000
Author(s):
Li Haoming1; 2;  Qu Yuqing1; 3;  Wang Xianling1;  Guo Qinghua1; Chen Yulong1;  Pei Yu1;  Du Jin1;  Yan Wenhua1;  Zang Li1;  Gu Weijun1;  Dou Jingtao1;  Ba Jianming1;  Lyu Zhaohui1;  Mu Yiming1.
1Department of Endocrinology, The First Clinical Center of Chinese PLA General Hospital, Beijing 100853, China; 2Department of Endocrinology, Shexian Hospital, Handan 056400, China; 3Department of Endocrinology, Yantai Yuh
关键词:
神经内分泌肿瘤;  胰腺;  胰岛素瘤;  多发性内分泌腺瘤病
Keywords:
Neuroendocrine neoplasms;  Pancreas;  Insulinoma;  Multiple endocrine neoplasia type 1
DOI:
10.3760/cma.j.cn121383-20200729-07073
摘要:
目的 总结了较大样本功能性胰腺神经内分泌肿瘤(PanNENs)的临床特点及诊疗经过。方法 回顾性分析2000年1月至2020年7月中国人民解放军总医院第一医学中心经病理诊断确诊的功能性PanNENs患者的临床资料、相关激素检查、影像学检查及病理结果。结果 本研究共纳入286例患者(男性103例,女性183例),平均年龄为(45.55±15.23)岁,平均病程为24(12,60)个月。286例患者中,最常见罹患的是胰岛素瘤(266/286), 其次是胰高血糖素瘤(10/286)、生长抑素瘤(3/286)、异位分泌促肾上腺皮质激素(ACTH)的肿瘤(3/286)、胃泌素瘤(2/286)和血管活性肠肽(VIP)瘤(2/286)。胰岛素瘤患者中,9例为多发性内分泌腺瘤病1型(MEN1)患者。肿瘤定位明确且局限的280例患者接受手术治疗。5例远处转移或者术后复发者同时接受介入治疗或药物化疗,经治疗后激素增多的症状得到明显缓解。术后肿瘤病理分级, 神经内分泌肿瘤(NET)G1占41.95%、 NET G2占54.90%、NET G3占3.15%、神经内分泌癌(NEC)占0%。结论 多学科协作并进行系统的内分泌评估和精确定位肿瘤,精准施治,对改善功能性PanNENs患者的预后十分重要。
Abstract:
Objective To summarize the clinical characteristics and management of functional pancreatic neuroendocrine neoplasms(PanNENs)in a large Chinese cohort.Methods Retrospective review was performed in patients with a definite diagnosis of functional PanNENs administrated in the First Clinical Center of Chinese PLA Hospital between January 2000 and July 2020. The clinical data, related hormone examinations, imaging examinations and pathological findings were extracted from their medical records and analyzed.Results A total of 286 patients(male 103, female 183)aged(45.55±15.23)years were diagnosed to have definite functional PanNENs, with a duration of 24(12,60)months. The most frequent functional PanNENs was insulinoma(266/286), followed by glucagonoma(10/286), somatostatinoma(3/286), adrenocorticotropic hormone(ACTH)producing-tumor(3/286), gastrinomas(2/286)and vasoactive intestinal polypeptide(VIP)tumor(2/286). Nine patients were diagnosed to have multiple endocrine neoplasia type 1(MEN1)in which all the associated functional PanNENs were insulinomas. Two hundred and eighty patients with tumor localized in pancreas or with limited metastasis underwent surgery. The symptoms associated with hormonal over-secretion relieved significantly after surgery. Five patients with unresectable or recurrent metastases after surgery underwent systemic chemotherapy or other targeted therapies. With these various therapies, the symptoms also partially relieved. According to findings in pathological and immunochemical examination, all the functional PanNENs were categorized to neuroendocrine tumors(NET)G1(41.95%), NET G2(54.90%), NET G3(3.15%), and neuroendocrine carcinoma(NEC)(0%).Conclusion Multidisciplinary collaboration is essential for precise diagnosis and tumor localization, as well as successful surgery or other targeted therapies, to improve the prognosis of patients suffered from these disorders.

参考文献/References:

[1] 殷美琦,凌菁,陆而立,等. 以低血糖为首发表现的伴肝脏多发转移的恶性胰岛素瘤1例并文献复习[J].国际内分泌代谢杂志,2019,39(6):429-432.DOI:10.3760/cma.j.issn. 1673-4157.2019.06.017.
[2] Yu J,Ping F,Zhang H,et al. Clinical management of malignant insulinoma:a single institution's experience over three decades[J].BMC Endocr Disord,2018,18(1):92.DOI:10.1186/s12902-018-0321-8.
[3] Rindi G,Klimstra DS,Abedi-Ardekani B,et al. A common classification framework for neuroendocrine neoplasms:an International Agency for Research on Cancer(IARC)and World Health Organization(WHO)expert consensus proposal[J].Mod Pathol,2018,31(12):1770-1786.DOI:10.1038/s41379-018-0110-y.
[4] 童安莉.多发性内分泌腺瘤病1型中胰腺神经内分泌肿瘤的诊治进展与展望[J].中华消化杂志,2019,39(8):525-527.DOI:10.3760/cma.j.issn.0254-1432.2019.08.006.
[5] Modlin IM,Lye KD,Kidd M. A 5-decade analysis of 13,715 carcinoid tumors[J].Cancer,2003,97(4):934-959.DOI:10.1002/cncr.11105.
[6] Hallet J,Law CH,Cukier M,et al.Exploring the rising incidence of neuroendocrine tumors:a population-based analysis of epidemiology,metastatic presentation,and outcomes[J].Cancer,2015,121(4):589-597.DOI:10.1002/cncr.29099.
[7] Aggeli C,Nixon AM,Karoumpalis I,et al.Laparoscopic surgery for pancreatic insulinomas:an update[J].Hormones(Athens),2016,15(2):157-169.DOI:10.14310/horm.2002.1670.
[8] Gong S,Li Z,Liu XB,et al. Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy:a case report[J].Medicine(Baltimore),2019,98(50):e18275.DOI:10.1097/MD.0000000000018275.
[9] Duan F,Bai YH,Cui L,et al. CT during celiac artery angiography for localization of clinically suspected small insulinomas[J].Cancer Imaging,2018,26; 18(1):22.DOI:10.1186/s40644-018-0155-7.
[10] Raina A,Conrad MA,Sahn B,et al. Endoscopic ultrasound with or without fine-needle aspiration has a meaningful impact on clinical care in the pediatric population[J].Endosc Ultrasound,2017,6(3):195-200.DOI:10.4103/eus.eus_2_17.
[11] Nockel P,Babic B,Millo C,et al. Localization of insulinoma using 68Ga-DOTATATE PET/CT scan[J].J Clin Endocrinol Metab,2017,102(1):195-199.DOI:10.1210/jc.2016-3445.
[12] Gao H,Wang W,Xu H,et al. Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis[J].Pancreatology,2019,19(3):472-477.DOI:10.1016/j.pan.2019.02.011.
[13] Niitsu Y,Minami I,Izumiyama H,et al. Clinical outcomes of 20 Japanese patients with insulinoma treated with diazoxide[J].Endocr J,2019,66(2):149-155.DOI:10.1507/endocrj.EJ18-0353.
[14] Marx SJ. Recent topics around multiple endocrine neoplasia type 1[J].J Clin Endocrinol Metab,2018,103(4):1296-1301.DOI:10.1210/jc.2017-02340.
[15] Ishida H,Lam AK. Pancreatic neuroendocrine neoplasms: the latest surgical and medical treatment strategies based on the current World Health Organization classification[J].Crit Rev Oncol Hematol,2020,145:102835.DOI:10.1016/j.critrevonc.2019.102835.

备注/Memo

备注/Memo:
通信作者:王先令,Email:wangxianling1972@sohu.com
李浩明和曲玉清为共同第一作者 基金项目:首都卫生发展科研专项(首发2011-5001-06)
更新日期/Last Update: 2021-05-20